T2 BiosystemsTTOO
13F holders, Q4 2024 (December 31)26holders +5
8new positions
5sold out
$0.42avg. 13F price*
At the end of Q4 2024, 26 institutions reported holding T2 Biosystems Inc. (TTOO) in their 13F filings, up 5 from Q3 2024. 8 opened new positions and 5 sold out. The largest holders were Vanguard Group Inc. ($65K), Geode Capital Management, LLC ($60K) and UBS Group AG ($58K).
- Company
- T2 Biosystems Inc.
- CUSIP
- 89853L302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $79K |
| Exits | 5 | $2.8M |
All 13F filers, Q3 2024 → Q4 2024: 394,724 shares bought and 1,674,725 shares sold, net −1,280,001 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Vanguard Group Inc. | 0.00% | Reduce -60.3% | 154,814 | $65K |
| Geode Capital Management, LLC | 0.00% | Add +56.5% | 142,196 | $60K |
| UBS Group AG | 0.00% | Add +13923900.0% | 139,240 | $58K |
| Squarepoint Ops LLC | 0.00% | New | 92,983 | $39K |
| BlackRock, Inc. | 0.00% | No change | 76,827 | $32K |
| State Street Corp. | 0.00% | No change | 63,743 | $27K |
| Susquehanna International Group, LLP | 0.00% | Add +26.6% | 57,554 | $24K |
| Virtu Financial LLC | 0.00% | New | 31,162 | $13K |
| Northern Trust Corp. | 0.00% | No change | 27,142 | $11K |
| Two Sigma Securities, LLC | 0.00% | New | 22,814 | $10K |
| Kingswood Wealth Advisors, LLC | 0.00% | New | 20,000 | $8K |
| Goldman Sachs Group Inc. | 0.00% | No change | 14,750 | $6K |
| Two Sigma Investments, LP | 0.00% | New | 11,936 | $5K |
| Nordwand Advisors, LLC | 0.00% | New | 10,000 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +121.1% | 5,304 | $2K |
| Group One Trading LLC | 0.00% | No change | 289 | $121 |
| Citigroup Inc. | 0.00% | New | 237 | $100 |
| SBI Securities Co., Ltd. | 0.00% | — | 99 | $42 |
| Bank of America Corp. | 0.00% | Add +46.4% | 82 | $34 |
| Osaic Holdings, Inc. | 0.00% | Reduce -81.5% | 38 | $15 |
| JPMorgan Chase & Co. | 0.00% | New | 33 | $14 |
| Morgan Stanley | 0.00% | No change | 14 | $6 |
| US Bancorp \de | 0.00% | No change | 3 | $1 |
| Barclays PLC | 0.00% | Reduce -99.0% | 1 | $0 |
| Royal Bank of Canada | 0.00% | Reduce -93.2% | 271 | $0 |
| Cwm, LLC | 0.00% | No change | 310 | $0 |
"% of holder's portfolio" is TTOO's weight in each manager's 13F, not the share of T2 Biosystems Inc. the manager owns.